Topic
Multidistrict Litigation
457 published works
Drug & Device Law
Briefing Underway in Appeal of Half-Billion-Dollar Verdict in Pinnacle MDL
This post comes from the Cozen O’Connor side of the blog. We’ve been following the Pinnacle MDL closely through the last two bellwether trials, starting with the news coming out…
Drug & Device Law
JPML Refuses MDL for Proton Pump Inhibitor Kidney Injury Cases
A multidistrict litigation (MDL) can be a sound way of managing a mass tort. Efficiencies are available (e.g., deposing company witnesses only once) and the U. of Chicago part of us…
Civil Procedure & Federal Courts Blog
House May Receive Amendments to Bills on Rule 11, Class Actions, MDLs, and Joinder
The House of Representatives Committee on Rules has announced that it will meet the week of March 6 “to grant a rule that may provide a structured amendment process for…
Class Action Countermeasures
What’s in FICALA? Part 2 – MDLs
Earlier this month, I wrote about the class-action provisions of the new Fairness in Class Action Litigation Act, which has passed out of the Judiciary Committee and is headed for…
Civil Procedure & Federal Courts Blog
Burch on MDL Monopolies
Elizabeth Burch has recently published Monopolies in Multidistrict Litigation, 70 Vand. L. Rev. 67 (2017). Here’s the abstract:When transferee judges receive a multidistrict proceeding, they select a few lead plaintiffs’…
Mass Tort Litigation Blog
H.R. 985: An Attempt to Undermine Class Actions & MDL
Class actions and MDL have real problems that need fixing. I have written about these problems at length, most recently in Aggregation as Disempowerment. But the new bill that just passed…
Drug & Device Law
You Can Hide But You Can’t Run
Is the lesson learned by at least one plaintiff’s counsel in the In re Yasmin & Yaz Mktg. Sales Practices & Prod. Liab. Litig. We already know mass tort MDLs…
Drug & Device Law
The Multi-District Litigation Statute Needs Rewriting
By Bexis
It’s hard to believe that, with over half of all cases pending in the federal courts now docketed in multi-district litigations (“MDLs”), the statutory basis for all this litigation is…
Drug & Device Law
Another Modest Proposal (This Time, About Discovery)
By Bexis
Bexis recently attended the “Emerging Issues in Mass-Tort MDLs Conference” sponsored by Duke Law School (those of us from Philly remember Duke as part of “Black Saturday” back in 1979). …
Civil Procedure & Federal Courts Blog
Coleman on One Percent Procedure
Brooke Coleman has posted on SSRN her article, One Percent Procedure, 91 Washington Law Review 1005 (2016). Here’s the abstract:In this election year, political rhetoric about the one percent is…